Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kv1.5 (KCNA5) is a voltage-gated potassium channel that belongs to the Shaker-related family. It forms tetrameric channels responsible for the ultra-rapid delayed rectifier potassium current (I_{Kur}), which is crucial for repolarizing cardiac action potentials, particularly in atrial tissue. It also plays a role in regulating resting membrane potential in pulmonary artery smooth muscle and may influence insulin secretion in pancreatic beta cells. Kv1.5 is implicated in diseases such as atrial fibrillation, sudden cardiac death, and pulmonary arterial hypertension, making it a target for antiarrhythmic drug development, particularly for treating atrial fibrillation.
Blockade of Kv1.5 channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated potassium channel Kv1.5 (Kv1.5).